机译:在血清HBeAg和HBV DNA阴性的肝移植受者中,抗病毒药物预防撤药可能是可行的
Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, First Afifliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China;
Key Laboratory of Combined Multi-organ Trans-plantation, Ministry of Public Health, Key Laboratory of Organ Trans-plantation and Collaborative Innovation Center for Diagnosis Treatment of Infectious Diseases, Hangzhou 310003, China;
Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, First Afifliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China;
Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, First Afifliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China;
Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, First Afifliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China;
Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, First Afifliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China;